Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Givaudan-Roure

This article was originally published in The Rose Sheet

Executive Summary

Givaudan-Roure: In line with its "extensive worldwide expansion plan," the firm is devoting $8 mil. to enlarging its Teaneck, NJ-based North American Regional headquarters, the company says. Scheduled for completion in April 1996, the expansion will add development, testing and evaluation labs for Givaudan-Roure's consumer products development sector. The firm also recently opened its Asia Pacific Regional Center in Singapore. The 15,000 square meter center, which cost Givaudan-Roure approximately $35 mil. (CHF 40 mil.) to build, will be capable of producing 4,000 tons of flavors and fragrances yearly when "fully operational," the company claims. In addition, the Asia Pacific offices will provide enhanced creation and application facilities, the firm states...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001630

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel